Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0015
+0.0000 (1.73%)
At close: Mar 19, 2026
Halberd Revenue
Halberd had revenue of $1.22K in the quarter ending April 30, 2022, with 6.38% growth. This brings the company's revenue in the last twelve months to $6.94K. In the fiscal year ending July 31, 2021, Halberd had annual revenue of $5.24K.
Revenue (ttm)
6.94K
Revenue Growth
n/a
P/S Ratio
158.31
Revenue / Employee
2.31K
Employees
3
Market Cap
1.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2021 | 5.24K | - | - |
| Jul 31, 2020 | - | - | - |
| Jul 31, 2011 | 80.08K | 46.68K | 139.74% |
| Jul 31, 2010 | 33.40K | 25.49K | 322.00% |
| Jul 31, 2009 | 7.92K | 900.00 | 12.83% |
| Jul 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evofem Biosciences | 20.18M |
| Emmaus Life Sciences | 11.89M |
| EV Biologics | 9.47M |
| International Stem Cell | 9.39M |
| Lyra Therapeutics | 600.00K |
| Eastgate Biotech | 137.64K |